[Primary renal marginal zone B lymphoma]. 2023

Amine Benmoussa, and I Moukrim, and N Khoubila, and S Cherkaoui, and M Lmchaheb, and M Qachouh, and M Rachid, and A Madani
Service d'Hématologie clinique et d'Oncologie pédiatrique, Faculté de Médecine et de Pharmacie Hassan II Casablanca, CHU 20 Août, Casablance, Maroc.

Primary renal marginal zone B lymphoma is extremely rare. The renal involvement by the lymphoma is most often a manifestation of a disseminated disease. We report the case of a 53-year-old patient who presented lower back pain and kidney failure. The renal biopsy showed a marginal zone B lymphoma type MALT and the PET scan showed bilateral renal involvement. A treatment based on rituximab combined with chemotherapy (cyclophosphamide, prednisone and oncovin) was started with good outcome.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069283 Rituximab A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS. CD20 Antibody, Rituximab,GP2013,IDEC-C2B8,IDEC-C2B8 Antibody,Mabthera,Rituxan,IDEC C2B8,IDEC C2B8 Antibody,Rituximab CD20 Antibody
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D014750 Vincristine An antitumor alkaloid isolated from VINCA ROSEA. (Merck, 11th ed.) Leurocristine,Citomid,Farmistin,Oncovin,Oncovine,Onkocristin,Vincasar,Vincasar PFS,Vincristin Bristol,Vincristin medac,Vincristine Sulfate,Vincrisul,Vintec,cellcristin,PFS, Vincasar,Sulfate, Vincristine
D018442 Lymphoma, B-Cell, Marginal Zone Extranodal lymphoma of lymphoid tissue associated with mucosa that is in contact with exogenous antigens. Many of the sites of these lymphomas, such as the stomach, salivary gland, and thyroid, are normally devoid of lymphoid tissue. They acquire mucosa-associated lymphoid tissue (MALT) type as a result of an immunologically mediated disorder. Lymphoma, Mucosa-Associated Lymphoid Tissue,MALT Lymphoma,Marginal Zone B-Cell Lymphoma,Lymphoma of Mucosa-Associated Lymphoid Tissue,Mucosa-Associated Lymphoid Tissue Lymphoma,Lymphoma of Mucosa Associated Lymphoid Tissue,Lymphoma, MALT,Lymphoma, Mucosa Associated Lymphoid Tissue,Lymphomas, MALT,MALT Lymphomas,Marginal Zone B Cell Lymphoma,Mucosa Associated Lymphoid Tissue Lymphoma

Related Publications

Amine Benmoussa, and I Moukrim, and N Khoubila, and S Cherkaoui, and M Lmchaheb, and M Qachouh, and M Rachid, and A Madani
January 2005, European journal of dermatology : EJD,
Amine Benmoussa, and I Moukrim, and N Khoubila, and S Cherkaoui, and M Lmchaheb, and M Qachouh, and M Rachid, and A Madani
June 2006, American journal of clinical pathology,
Amine Benmoussa, and I Moukrim, and N Khoubila, and S Cherkaoui, and M Lmchaheb, and M Qachouh, and M Rachid, and A Madani
January 2008, Indian journal of pathology & microbiology,
Amine Benmoussa, and I Moukrim, and N Khoubila, and S Cherkaoui, and M Lmchaheb, and M Qachouh, and M Rachid, and A Madani
January 1998, European journal of haematology,
Amine Benmoussa, and I Moukrim, and N Khoubila, and S Cherkaoui, and M Lmchaheb, and M Qachouh, and M Rachid, and A Madani
January 2012, The Journal of craniofacial surgery,
Amine Benmoussa, and I Moukrim, and N Khoubila, and S Cherkaoui, and M Lmchaheb, and M Qachouh, and M Rachid, and A Madani
October 2011, Dermatology online journal,
Amine Benmoussa, and I Moukrim, and N Khoubila, and S Cherkaoui, and M Lmchaheb, and M Qachouh, and M Rachid, and A Madani
July 2006, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,
Amine Benmoussa, and I Moukrim, and N Khoubila, and S Cherkaoui, and M Lmchaheb, and M Qachouh, and M Rachid, and A Madani
May 2010, Leukemia research,
Amine Benmoussa, and I Moukrim, and N Khoubila, and S Cherkaoui, and M Lmchaheb, and M Qachouh, and M Rachid, and A Madani
June 2010, Critical reviews in oncology/hematology,
Amine Benmoussa, and I Moukrim, and N Khoubila, and S Cherkaoui, and M Lmchaheb, and M Qachouh, and M Rachid, and A Madani
December 2016, Dermatology online journal,
Copied contents to your clipboard!